Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

Treatments and trials you qualify for
Education for your stage of care
Financial support for your medications
Solutions to your side effects

Innovations in Whole-Genome Sequencing: Shaping the Future of Multiple Myeloma Care

Name: Innovations in Whole-Genome Sequencing: Shaping the Future of Multiple Myeloma Care
Start: 2026-03-31T15:00:00-04:00
End: 2026-03-31T16:00:00-04:00

Mar 31, 2026

03:00PM - 04:00PM EDT

Online Event

Overview

Whole genome sequencing (WGS) is one of the newest areas of innovation in myeloma, opening doors to a deeper understanding of the disease and more personalized care. In this patient-focused webinar, Francois Aguet will explain what whole genome sequencing is, why it matters in myeloma care, what insights it can provide today, and where it is currently available. We will also explore how WGS may shape future treatment decisions, helping patients and families better understand how emerging science could impact the myeloma experience.

Agenda

3:00 PM

Introductions

Cynthia Cahoon, RN

Cindy introduces the agenda of the event and featured speaker Francois Aguet, PhD

3:05 PM

Presentation

Francois Aguet, PhD

Francois talks about genome sequencing in myeloma

3:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

Speakers & Moderators

Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Francois Aguet, PhD

Francois Aguet is a computational biologist and currently leads Research and Computational Biology at Predicta Biosciences, a precision oncology company leveraging multiomics and cell-based liquid biopsies to develop innovative diagnostic and therapeutic solutions. Prior to this, he served as an Associate Director at Illumina’s Artificial Intelligence Laboratory and as a Group Leader at the Broad Institute, where his work focused on uncovering the genetic foundations of human diseases. He has contributed to several major research consortia, including the Genotype-Tissue Expression (GTEx) Project, the Trans-Omics for Precision Medicine (TOPMed) Program, the Clinical Proteomic Tumor Analysis Consortium (CPTAC), and the Developmental GTEx (dGTEx) project, helping to advance the understanding of genetic effects across human tissues.